Daniel Ryweck
Förmögenhet: 2 068 $ per 2026-06-30
Förmögenhet: 2 068 $ per 2026-06-30
Mr. Daniel E.
Ryweck is a Chief Financial Officer at Silo Pharma, Inc. Mr. Ryweck was previously employed as a Chief Financial Officer by Sun BioPharma, Inc. and a Controller by SUI Group Holdings Ltd. He also served on the board at Dala Petroleum Corp.
and KonaTel, Inc. He received his undergraduate degree from The Curtis L.
Carlson School of Management.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SILO PHARMA INC 0,03 % | 2025-08-25 | 333 ( 0,03 % ) | 2 068 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| SILO PHARMA, INC. | Finansdirektör/CFO | 2022-09-27 |
| Företag | Position | Slut |
|---|---|---|
Dala Petroleum Corp.
Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Direktör/Styrelseledamot | 2017-08-31 |
| KONATEL, INC. | Direktör/Styrelseledamot | 2017-08-31 |
| SUN BIOPHARMA INC | Finansdirektör/CFO | 2015-09-01 |
| SUI GROUP HOLDINGS LIMITED | Compliance Officer | 2019-12-31 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Mill City Ventures III Ltd.
Mill City Ventures III Ltd. Finance/Rental/LeasingFinance Provides short-term finance solutions to private businesses, micro and small-cap public companies and high-net-worth individuals | Finance |
Silo Pharma, Inc.
Silo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a developmental stage biopharmaceutical company that focuses on merging traditional therapeutics with psychedelic research | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dala Petroleum Corp.
Dala Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Energy Minerals |
Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for pancreatic cancer and chronic pancreatitis | Health Technology |
KonaTel, Inc.
KonaTel, Inc. Wireless TelecommunicationsCommunications Provides hosted communication platform as a service and mobile solutions | Communications |
Välj din utgåva
All finansiell information anpassad till den nationella nivån